ATL-105
/ AATec Medical
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 07, 2026
ATL-105, a novel multimodal serine protease inhibitor with immunomodulatory and anti-infective properties for the treatment of non-CF bronchiectasis
(WBC 2026)
- No abstract available
Immunomodulating • Bronchiectasis • Non‐Cystic Fibrosis Bronchiectasis • Pulmonary Disease • Respiratory Diseases
1 to 1
Of
1
Go to page
1